{
    "organizations": [],
    "uuid": "5d3ae2364df3ce1bda470e3c1b1809d0f8d43771",
    "author": "",
    "url": "https://www.reuters.com/article/brief-zynerba-pharmaceuticals-initiates/brief-zynerba-pharmaceuticals-initiates-open-label-phase-2-trial-of-zyn002-in-developmental-and-epileptic-encephalopathies-idUSASC09VDH",
    "ord_in_thread": 0,
    "title": "BRIEF-Zynerba Pharmaceuticals Initiates Open Label Phase 2 Trial Of ZYN002 In Developmental And Epileptic Encephalopathies (DEE)",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 10, 2018 / 11:47 AM / Updated 8 minutes ago BRIEF-Zynerba Pharmaceuticals Initiates Open Label Phase 2 Trial Of ZYN002 In Developmental And Epileptic Encephalopathies (DEE) Reuters Staff \nApril 10 (Reuters) - Zynerba Pharmaceuticals Inc: \n* ZYNERBA PHARMACEUTICALS INITIATES OPEN-LABEL PHASE 2 TRIAL OF ZYN002 IN DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES (DEE) \n* EXPECTS TO REPORT TOPLINE RESULTS FROM PHASE 2 BELIEVE 1 CLINICAL TRIAL IN 2019 Source text for Eikon: Further company coverage:",
    "published": "2018-04-10T14:44:00.000+03:00",
    "crawled": "2018-04-10T15:06:55.020+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "initiate",
        "open",
        "label",
        "phase",
        "trial",
        "zyn002",
        "developmental",
        "epileptic",
        "encephalopathy",
        "dee",
        "reuters",
        "staff",
        "april",
        "reuters",
        "zynerba",
        "pharmaceutical",
        "inc",
        "zynerba",
        "pharmaceutical",
        "initiate",
        "phase",
        "trial",
        "zyn002",
        "developmental",
        "epileptic",
        "encephalopathy",
        "dee",
        "expects",
        "report",
        "topline",
        "result",
        "phase",
        "believe",
        "clinical",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}